BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32016497)

  • 1. Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
    Baehr A; Trog D; Oertel M; Welsch S; Kröger K; Grauer O; Haverkamp U; Eich HT
    Strahlenther Onkol; 2020 May; 196(5):457-464. PubMed ID: 32016497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
    Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M
    J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.
    Arpa D; Parisi E; Ghigi G; Savini A; Colangione SP; Tontini L; Pieri M; Foca F; Polico R; Tesei A; Sarnelli A; Romeo A
    Sci Rep; 2020 Nov; 10(1):19321. PubMed ID: 33168845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
    Straube C; Combs SE; Bernhardt D; Gempt J; Meyer B; Zimmer C; Schmidt-Graf F; Vajkoczy P; Grün A; Ehret F; Zips D; Kaul D
    J Neurooncol; 2024 May; 168(1):49-56. PubMed ID: 38520571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.
    Bräutigam E; Lampl C; Track C; Nieder C; Pichler J; Hammer J; Geinitz H
    Clin Transl Oncol; 2019 May; 21(5):582-587. PubMed ID: 30284233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
    Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
    Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
    Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP
    Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation for recurrent glioblastoma multiforme.
    Barney C; Shukla G; Bhamidipati D; Palmer JD
    Chin Clin Oncol; 2017 Aug; 6(4):36. PubMed ID: 28841798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
    Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.
    Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N
    Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.
    Straube C; Elpula G; Gempt J; Gerhardt J; Bette S; Zimmer C; Schmidt-Graf F; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Nov; 193(11):897-909. PubMed ID: 28616821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
    Navarria P; Minniti G; Clerici E; Tomatis S; Pinzi V; Ciammella P; Galaverni M; Amelio D; Scartoni D; Scoccianti S; Krengli M; Masini L; Draghini L; Maranzano E; Borzillo V; Muto P; Ferrarese F; Fariselli L; Livi L; Pasqualetti F; Fiorentino A; Alongi F; di Monale MB; Magrini S; Scorsetti M
    J Neurooncol; 2019 Mar; 142(1):59-67. PubMed ID: 30515706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.